These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 39093298)
1. Iron Chelator Deferiprone Restores Iron Homeostasis and Inhibits Retinal Neovascularization in Experimental Neovascular Age-Related Macular Degeneration. Xu Y; Huang S; Zhou S; Wang X; Wei M; Chen X; Zong R; Lin X; Li S; Liu Z; Chen Q Invest Ophthalmol Vis Sci; 2024 Aug; 65(10):5. PubMed ID: 39093298 [TBL] [Abstract][Full Text] [Related]
2. The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice. Song D; Zhao L; Li Y; Hadziahmetovic M; Song Y; Connelly J; Spino M; Dunaief JL Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4525-32. PubMed ID: 24970260 [TBL] [Abstract][Full Text] [Related]
3. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119 [TBL] [Abstract][Full Text] [Related]
4. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Grieco S; Lee J; Lyubarsky A; Pratico D; Connelly J; Spino M; Harris ZL; Dunaief JL Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):959-68. PubMed ID: 21051716 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001 [TBL] [Abstract][Full Text] [Related]
6. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model. Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075 [TBL] [Abstract][Full Text] [Related]
7. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis. Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584 [TBL] [Abstract][Full Text] [Related]
9. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [TBL] [Abstract][Full Text] [Related]
10. Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. Ma X; Takahashi Y; Wu W; Chen J; Dehdarani M; Liang W; Shin YH; Benyajati S; Ma JX FASEB J; 2021 Dec; 35(12):e22058. PubMed ID: 34820908 [TBL] [Abstract][Full Text] [Related]
11. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization. Xia CH; Lu E; Zeng J; Gong X PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663 [TBL] [Abstract][Full Text] [Related]
12. Uncovering the role of ferroptosis in Bietti crystalline dystrophy and potential therapeutic strategies. Shen C; Yang Q; Chen K; Ma H; Wang X; Tong J; Shen Y; Cui H Cell Commun Signal; 2024 Jul; 22(1):359. PubMed ID: 38992691 [TBL] [Abstract][Full Text] [Related]
13. Sema3f Protects Against Subretinal Neovascularization In Vivo. Sun Y; Liegl R; Gong Y; Bühler A; Cakir B; Meng SS; Burnim SB; Liu CH; Reuer T; Zhang P; Walz JM; Ludwig F; Lange C; Agostini H; Böhringer D; Schlunck G; Smith LEH; Stahl A EBioMedicine; 2017 Apr; 18():281-287. PubMed ID: 28373097 [TBL] [Abstract][Full Text] [Related]
14. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. Kyosseva SV; Chen L; Seal S; McGinnis JF Exp Eye Res; 2013 Nov; 116():63-74. PubMed ID: 23978600 [TBL] [Abstract][Full Text] [Related]
17. Antioxidative effects of polypyrimidine tract-binding protein-associated splicing factor against pathological retinal angiogenesis through promotion of mitochondrial function. Dong L; Lin T; Li W; Hong Y; Ren X; Ke Y; Zhang X; Li X J Mol Med (Berl); 2021 Jul; 99(7):967-980. PubMed ID: 33770188 [TBL] [Abstract][Full Text] [Related]
18. Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration. Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Kautz L; Roth MP; Dunaief JL Am J Pathol; 2011 Jul; 179(1):335-48. PubMed ID: 21703414 [TBL] [Abstract][Full Text] [Related]
19. Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Song D; Song Y; Hadziahmetovic M; Zhong Y; Dunaief JL Free Radic Biol Med; 2012 Jul; 53(1):64-71. PubMed ID: 22579919 [TBL] [Abstract][Full Text] [Related]
20. The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy. Rao SS; Portbury SD; Lago L; Bush AI; Adlard PA J Alzheimers Dis; 2020; 77(2):753-771. PubMed ID: 32741833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]